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Risk Factors for Drug Resistance-Tuberculosis Among Tuberculosis Cases in Dire Dawa Administration, Ethiopia: Case Control Study  Teklu Molie(MPH)1      Hussen Mohammed(MPH)2      Abeya Degefe (MA)3      Negga Baraki(MPH)4  Abdurehman Gelmo (MD)5      Abdo Mume (BSC)5. 1.BL/TB/HIV and MDR TB Program, Dire Dawa Regional Health Bureau, Po Box  177, Dire Dawa 2.College of Medicine and Health Science, Dire Dawa University, Po.Box-1362, Dire Dawa 3.College of Social Sciences and Humanities, Dire Dawa University, Po.Box-1362, Dire Dawa 4.College of   Health and Medicinal Science, Haramaya University, Po.Box- 138 , Haramya 5.Dil Chora Referral Hospital, Dire Dawa Regional Health Bureau, Dire Dawa 6.Regional  Laboratory, Dire Dawa Regional Health Bureau, Dire Dawa, Dire Dawa  *This Study was sponsored by TRAC-Ethiopia Abstract  Background: The 2011 world health organization global tuberculosis report estimated the presence of 650,000 cases of multi-drug resistance tuberculosis among the world’s 12.0 million prevalent cases of tuberculosis. Drug-resistant tuberculosis is a man-made problem, largely being the consequence of human error as a result of individual or combination of factors related to management of drug supply, patient management, prescription of chemotherapy, and patient adherence.  Objective:  To assess the risk factors associated with drug resistant tuberculosis among tuberculosis cases in Dire Dawa administration council from June to September 2014..  Methods: A health facility based unmatched case control study design was conducted.  All diagnosed drug resistant tuberculosis were taken as cases and randomly selected sensitive TB cases were considered as controls. The sample size was 270 (216 for control and 54 for cases) with case to control ratio 1:4, using Epi Info V.6.  Finally, data was collected by pre tested questionnaire and coded, edited, entered by Epi Info version 6.0 and analyzed by using SPSS version 16.0. Univariate, bivariate analysis, chi- square test and multivariable logistic analysis were conducted with consideration of P value < 0.05 with 95% CI.  Result: In multi logistic regression, three variables; unemployment, pre-treatment for TB and unsuccessful treatment outcome were found to fit the model. . That is, subjects treated before for TB were 190.7 times more likely to develop DR-TB than counterpart AOR=190.7 with 95% CI (14.53, 2502), unemployed subjects were 2.83 times more likely at risk of DR-TB than employed AOR=2.83 with 95% CI (1.02, 7.86) & those who were unsuccessfully treated were 343 times more likely at risk of DR-TB than with successful treatment outcome AOR=343 with 95% CI (29.9, 3985) Conclusion: Previous history of treatment, unemployment and unsuccessful treatment outcome were significant risk factor associated with DR-TB. Therefore, DOTS program should be strengthened to increase patient adherence for successful treatment of patients.  Keywords: TB, drug resistance TB, Risk-factor  1. INTRODUCTION Drug-Resistant Tuberculosis (DR-TB) is a man-made problem, largely being the consequence of human error as a result of individual or combination of factors related to management of drug supply, patient management, prescription of chemotherapy, and patient adherence(1).The increasing prevalence of infection with drug-resistant Mycobacterium tuberculosis represents a global public health emergency. (4).The 2011 WHO Global TB Report estimated the presence of 650,000 cases of MDR-TB among the world’s 12.0 million prevalent cases of TB. (4). Ethiopia is among 27 high MDR-TB burden countries that carry 87% of the total global burden and one of the four countries in Africa (i.e. South Africa, Nigeria and DRC).  The 2003-2005 drug resistance TB survey result showed, 1.6% of new cases and 11.8 % of retreatment cases in Ethiopia were resistance to isoniazid and ri-fampicin, (MDR-TB) (4).  Ethiopian MDR-TB implementation frame work developed through adaption of Stop TB Strategy. It addresses TB/HIV and MDR-TB, strengthening of health systems, engagement of community and all care providers.  Moreover, the strategy also entails operational research, in addition to DOTS and DOTS-plus. Each of the six components of the strategy has an important contribution to the success of the program (4).  There are several reasons for emerging DR-TB in developing countries lack the laboratory facilities for the diagnosis of MDR-TB and the clinical expertise and chemotherapeutic agents for its management. Although effective second-line drugs are available, they are expensive and treatment takes 18– 24 months (7). Hence, there has been a recent shift in the international attitude towards dealing with the MDR-TB burden. The goal now is to provide universal access to 
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diagnosis and treatment of MDR-TB by the year 2015 (similar to the goal of universal access to ART) (6).  The ultimate strategy to control drug-resistant tuberculosis is one that implements comprehensive approach incorporating treatment of drug-resistant tuberculosis based upon principles closely related to those of the  general DOTS strategy for TB control: sustained political commitment; a rational case-finding strategy including accurate, timely diagnosis through quality assured culture and DST; appropriate treatment strategies that use second-line drugs under proper case management conditions; uninterrupted supply of quality-assured anti-tuberculosis drugs; standardized recording and reporting system (4).Coming to Dire Dawa administration, 22 and 34 in 2005EFY and 2006 EFY respectively, which make the total all number of MDR-TB currently on treatment 56. This study identified the factors associated with DR-TB and used for policy makers, program planners and service providers to improve TB services  2. The Research Question and Hypotheses  2.1 Research Questions 
 What are the major risk factors associated with drug resistance among TB cases in Dire Dawa Administration?   2.2 Hypothesis  
  Socio demographic factors of the patients have no effect on development of DR-TB.   2.3 Objective  The objective of this study was to assess risk factors associated with DR-TB among TB cases in Dire     Dawa administration from June to September 2014.  3. Methods Study was conducted in Dire Dawa administration located in eastern part of Ethiopia from June to September 2014.The study design was health facilities based unmatched case control. Source population of the study was all forms of TB cases and study population was all diagnosed DR-TB for cases (patients with laboratory confirmed DR-TB at least for Rifampicin and randomly selected sensitive TB cases for controls (all sensitive TB patients those who completed treatment during data collection period) were included in the study.   3.1 Inclusion and Exclusion Criteria 3.1.1 Inclusion Criteria  All TB cases age greater than 10 years old were included in the study because their treatment protocols were different from that of less than ten years according to the compressive TBL and TB/HIV Ethiopia treatment guideline 2013. 3.1.2 Exclusion Criteria  Critically ill TB patients/those who couldn’t respond were excluded.   3.2 Sample Size Determination and Sampling Techniques  Double population proportion formula was used for sample size calculation by using Epi Info version 6 by considering household contact as predictor variable(OR=5)(22), 4:1 control to case ratio,  4.4% percentage exposure among controls ; 80% power and 95% confidence level. The sample size was 270(216 controls and 54 cases) including 10% non-response rates. A systematic random sampling technique was used to select control (those who were on sensitive Tb treatment and who completed treatment within data collection period) and DR-TB patients diagnosed at health facilities in the administration. The sampling frame was unit TB register.  3.3 Study variables The independent variables include socio demographic variables, treatment category/regimen, adherence, co-infection (HIV/AIDS), treatment supporter and household contact. And the dependent variable for this study was DR-TB.  3.4 Data Collection Instrument/tool   Inter viewer administered structured questionnaire and check list were used to collect data   3.5 Data collection Procedure  Data was collected by trained Bsc Nurse and public health professionals.   
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3.6 Data Quality control  Data collectors and supervisors trained; tools were pre tested on 5% sample size and the collected data were submitted to the supervisors on daily based and feedback were given on the next day morning  3.7 Data Analysis   The data were coded and entered into the data sheet using EPI info version 6.0, then exported to SPSS version 16.0 for further analysis. All continuous variables were described using mean and standard deviation and frequency (%) for categorical data. For categorical data chi square was used and bi-variate analysis and multivariate logistic regression were applied to determine predictor variables on the outcome variables at 95% CI  3.8 Ethical consideration   Proposal was approved by Institution Health Research Ethics Review Committee (IHRERC) of Collage of Health and Medical Sciences, Haramaya University and cooperation letter was obtained from Dire Dawa regional Health Bureau.   4. Result A total of 265(53 cases and 212 control) were participated in the study which makes a response rate of 98%. Majority of study participants were males among cases and controls 36(67.9%) and 122(57.5%) respectively. The mean age was 31.1 (SD = 13.0) years for DR-TB cases and 32.0 (SD = 16.5) years for sensitive TB controls .Majority, 29(54.7%), were single among cases and 94(44.5%) were single among controls. (Table1).   4.1 Background Information  Table 1: The Background Information of the Participants  Characteristics                           Cases(N=53)   Controls (N=212) Number  Percentage  Number  Percentage  Sex           Male  36 67.9 122 57.5 Female  17 32.1 90 42.5 Total  53 100 212 100 Educational status Unable to read and write 5 9.4 59 27.8 Read and write only 5 9.4 13 6.1 1-8 grades 23 43.4 67 31.6 9-10 grades 6 11.3 36 17 Greater 10th grade 11 20.8 22 10.4 Diploma 2 3.8 10 4.7 Degree and above  1 1.9 5 2.4 Total  53 100 212 100 Marital status  Single 29 54.7 94 44.5 Married 16 30.2 86 40.8 Widowed 2 3.8 12 5.7 Divorced(legally) 4 7.5 10 4.7 Separated (not legally 2 3.8 9 4.3 Total  53 100 211 100 Religion  Muslim 24 45.3 138 65.1 Orthodox 25 47.2 68 32.1 Protestant 3 5.7 6 2.8 Catholic 1 1.9 0 0 Total  53 100.1 212 100 From the Table above, the percentage of the male participants (68 %) is almost as twice as that of the female participants (32%) for cases whereas, for control participants, the number of male and female participants was less different gender wise with 57.5 % and 42.5 % respectively. The percentage of participants in terms of their educational status, was highest for the primary education (43.4) followed by grade 10th complete for cases, and the same for the highest and followed by illiterate for (31.6%) and (27.8 %) respectively. Generally, most of the participants were illiterate or only at primary education.  Marital wise, more of the participants for both cases and control were single followed by divorced parents.  
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Religion wise, more cases belong to Orthodox (47.2) and more controls belong to Muslims (65.1%). Generally, more of the participants came from Muslim and Orthodox religions followed by insignificant portion of Protestant and Catholic religions.    4.2 DR-TB Conditions for Cases and Controls  Table 2: Drug Resistant and Sensitive TB related conditions for Cases and Controls in Dire Dawa, 2014 Characteristics                           Cases(N=53)   Controls (N=212) Number  Percentage  Number  Percentage  Treated for Tb before  Yes  50 94.3 30 14.2 No  3 5.7 182 85.8 Total  53 100 212 100 Contact person treated in HH Yes  9 17 36 17 No  24 45.3 158 74.5 I don’t know  20 37.7 18 8.5 Total  53 100 212 100 Ever interrupt/stop TB treatment         Yes  12 22.6 7 3.3 No  41 77.4 205 96.7 Total  53 100 212 100 Length of Interruption  <=10 days 4 33.3 6 85.7 >10 days  8 66.7 1 14.3 Total  12 100 7 100 Change Residence during TB Treatment Yes  9 17 25 11.8 No  44 83 187 88.2 Total  53 100 212 100 Smoke while TB RX Yes  5 9.4 13 6.1 No  48 90.6 199 93.9 Total  53 100 212 100 Miss TB treatment due to smoking Yes  2 40 1 7.7 No  3 60 12 92.3 Total  5 100 13 100 Ever chewed chat  Yes  14 26.4 52 24.5 No  39 73.6 160 75.5 Total  53 100 212 100 Miss TB treatment due to chewing chat  Yes  1 7.1 4 7.7 No  13 92.9 48 92.3 Total  14 100 52 100 Drink alcohol while TB RX Yes  10 18.9 21 9.9 No 43 81.1 191 90.1 Total  53 100 212 100 Miss TB RX doe to alcohol use Yes     1 1 10 2 9.5 No  9 90 19 90.5 Total  9 90 19 90.5  4.3 Associated Factors for drug resistant Tuberculosis   Based on the binary logistic regression, the variables associated with drug resistant were treated for TB before COR =101 with 95% CI (29.6, 345) and unsuccessful treatment outcome COR=89.3, CI (39.9, 228.5) , See table 
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3.  Table 3 Associated factors by Binary logistic regression in Dire Dawa 2014 Characteristics                           Cases(N=53)  Controls (N=212) COR at 95%CI    Number     Number  Sex  Male  36 122 1.56(0.83,2.95) Female  17 90 1 Educational level  Illiterate  10 72 2.21(1.1,4.7) Literate  43 140 1 Age in years        <=45 43 174 1.16(0.53,2.51) >45 10 35 1 Marital status  Single/divorced/widowed  37 125 1.59(0.83,3.0) Married  16 86 1 Residence  Urban  49 175 2.6(0.88,7.62) Rural   4 35 1 Occupation  Employed (governmental and private  ) 7 57 1 unemployed  46 155 2.42(1.03,5.7) Treated for TB before Yes  50 30 101(29.6,345) No  3 182 1 Contact person treated in HH/family Yes  9 36 1.65(0.71, 3.84)       No  24 158 1 Ever interrupt/stop TB treatment Yes  12 7 8.6(3.2, 23.2 ) No  41 205 1 For how long you interrupt/stop TB RX <=10 days                                                                            4 6 0.08(0.007,0.95) >10days 8 2 1 Frequency of drug provision during the intensive phase Daily  41 188 0.43(0.20,0.94) Weekly  12 24 1 Have treatment supporter Yes  51 147 1 No  2 54 9.37(2.20,39.8) Your treatment supporter Health extension worker                                               2 14 1.65(0.35,7.83) Neighbor 26 24 0.22(0.11, 0.45) From family members                                                   21 89 1 Diagnosed for chronic disease/illness (s) No/I don’t know                                                             22 147 1 Yes (DM,HTN,HIV/AIDS, others)                                31 65 0.73(0.19, 2.8) HIV/AIDs Status of the patient  Reactive                                                            10 7 1.3(0.6,2.85) Non-reactive                                                       43 205 1 Category of the patient New                                                                                 10 176 1 Retreatment  43 36 21(9.7,45.7)                   Intensive phase drug RHZE  12 119 1 RHZES   41 3 52(22.3,122.8) Drug  given during continuous phase RHE                                                                                   40 9 69.4(27.8,173.4) RH 13 203 1 Patients treatment out come Unsuccessful treatment outcome                                       44 11 89.3(39.9,228.5) Successful treatment outcome                                             9 201 1 
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4.4 Determinants of drug-resistant tuberculosis In multi logistic regression two variables were remain in the modal that is study subjects treated before for TB were 190.7 times more likely to develop drug resistance TB than counterpart AOR=190.7 with 95% CI (14.53, 2502) and those have unsuccessful treatment outcome were 343 times more likely to develop drug resistance TB than those have successful treatment outcome AOR=343 with 95% CI (29.9, 3985) .See table 4 Tabl 4.  Determinants of Drug-Resistant Tuberculosis by Logistic Regression Model Characteristics                           Cases(N=5)  Controls (N=212) COR at  95%CI    AOR at  95%CI   Number     Number      Education          Illiterate  10 72 2.21(1.1,4.7) 0.53(0.21,1.38) Literate  43 140 1 1 Age in years          <=45 43 174 1.16(0.53,2.51) 1.03(0.31,3.38) >45 10 35 1 1 Occupation          Employed (private and gov’t) 7 57 1 1 Unemployed  46 155 2.42(1.03,5.7) 2.83(1.02,7.86) Treated for TB before         Yes  50 30 101(29.6,345) 190.7 (14.53, 2502) No  3 182 1 1 Contact person treated in HH/family         Yes  9 36 1.65(0.71, 3.84)      2.5(0.64,9.76) No 24 158 1 1 Ever interrupt/stop TB treatment         Yes  12 7 8.6(3.2, 23.2 ) 2.25 (0.38,13.13) No 41 205 1 1 Have treatment supporter         Yes  51 147 1 1 No  2 54 9.37(2.20,39.8) 3.85(0.12,1.2) HIV/AIDs Status of the patient          Reactive                                                           10 7 1.3(0.6,2.85) 1.36(0.14,13.5) Non-reactive                                                      43 205 1 1 Category of the patient         New                                                                                10 176 1 1 Retreatment  43 36 21(9.7,45.7)                   2.63(0.43,16.04) Unsuccessful treatment outcome                                      44 11 89.3(39.9,228.5) 343(24,398.5) Successful treatment outcome                                             9 201 1 1  5. DISCUSSION A case control study with one to four numbers of cases and controls (1:4) was conducted by recruiting a total of 265 study subjects (53 drug resistant TB cases and 212 sensitive TB controls) to determine the risk factors associated with development of drug resistant TB. From socio-economic demographic variables, the unemployment status remain in the model as risk factor for the drug resistant TB (DR-TN) in which unemployed individuals among all cases account for 86.8 % and have 2.83 more risk of developing DR TB with AOR=2.83 at  95%CI (1.02,7.86) which was similar with study done in Namibia (18). Even if different studies undertaken in Nepal, India and Namibia, shows the association of age with DRTB (10,12,18), our study didn’t show statistical significant but more than half (58.5%) of cases lie in age group of 10-29 years that was  similar with study from Turkey as no age difference detected for risk factors (14). Concerning sex, in many epidemiological studies such as study undertaken in Iran, Belarus, Addis Ababa (18, 21, 22) showed that being male was a risk factor for developing DRTB than female counterpart but in India being female was a risk factor (13) but no association found between sex and drug resistant TB   in our study even majority of DRTB cases 67.9% were male which the same with study undertaken in Nigeria, Turkey (13,14). In addition to these, there were no association between education level and DRTB which was similar with finding from Belarus (21).No difference detected in marital status which in line with result from Turkey and Addis Ababa (14, 22). As we can see, the risk of developing DR-TB among previously treated individuals was 190.7 times increased than counterpart at 95% 
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(14.53, 2502). This finding is similar with different study done in Nepal, India, Turkey, Nepal, Namibia and Iran (10.13-14, 16-18).  An individual using category II regimen were 4.9 times high risk to develop DRTB that was similar with study done in Addis Ababa (22). House hold contact was not associated with DRTB in our study even if it was a risk factor for DRTB in different studies like in Namibia and Addis Ababa (17, 22). HIV/AIDS  is  not statistical significant in our study that was in line with study done in India and Addis Ababa (13,12) but in study done in Namibia (17) HIV/AIDS increase the risk of developing DRTB. The factors related to clients that we assessed were alcohol use that was18.9% among cases and 9.9% among  controls which is not significantly related to DR TB in our study even if it is one predictor in other studies under taken in the Nepal, Russia and Belarus (16, 20, 21).   Smoking tobacco, among smokers 9.5% from cases and 6.1% from controls, was not significantly related to DRTB in our finding that contradicts the finding from Belarus that show significant association (21). TB treatment interruption or missing dose was 22.6% and 3.3% of cases and controls respectively.  That was not statistically significant with AOR=2.25, 95% CI (0.38, 13.13) which contradicted studies under taken in the Europe meta-analysis, Russia & Addis Ababa (19, 20, 22). The factors related to health care providers of  allowing clients to take the drugs by themselves among cases,  22.6% and 19.8% of controls were not significantly related to DRTB  that contradicted  the study done in Paris, Thailand and Addis Ababa (11, 15, 22) .  6. CONCLUSION AND RECOMMENDATIONS 6.1 Conclusion  
 Unemployment, treated before for TB (previous history of treatment) and unsuccessful treatment outcome were significantly related with drug resistant TB 
 House hold contact,  treatment supporter, HIV/AIDS status were not significantly related with DRTB  
 Drinking alcohol, cigarette smoking , chat chewing and TB treatment interruption from client’s side and allowing clients to take the TB drugs by themselves from health care provided corner were not significantly related to DRTB   6.2 Recommendation 
• DOTS program should be strengthened to increase patient adherence for successful treatment of patients. 
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